81 related articles for article (PubMed ID: 11037054)
1. Dynamics of diurnal changes in serum concentration of TNF-alpha soluble receptors in gastrointestinal cancer patients.
Muc-Wierzgoń M; Baranowski MM; Madej K; Wierzgoń J; Kokot T; Brodziak A
J Biol Regul Homeost Agents; 2000; 14(3):204-8. PubMed ID: 11037054
[TBL] [Abstract][Full Text] [Related]
2. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
Zubelewicz-Szkodzinska B; Muc-Wierzgon M; Wierzgon J; Brodziak A
Oncol Rep; 2001; 8(1):207-12. PubMed ID: 11115600
[TBL] [Abstract][Full Text] [Related]
4. Is there a correlation between tumor necrosis factor alpha and soluble p-55 receptor plasma levels in advanced gastrointestinal cancer patients?
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
J Biol Regul Homeost Agents; 1996; 10(4):95-7. PubMed ID: 9604778
[TBL] [Abstract][Full Text] [Related]
5. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
6. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases.
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
Eur Cytokine Netw; 1998 Jun; 9(2):193-6. PubMed ID: 9681396
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
Jabłońska E; Kiluk M; Markiewicz W; Piotrowski L; Grabowska Z; Jabłoński J
Arch Immunol Ther Exp (Warsz); 2001; 49(1):63-9. PubMed ID: 11266093
[TBL] [Abstract][Full Text] [Related]
8. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
9. The estimation of endogenous tumor necrosis factor alpha and cortisol levels in serum in advanced neoplasm.
Baranowski M; Muc-Wierzgon M; Madej K; Wierzgoń J; Zubelewicz B
J Exp Clin Cancer Res; 1999 Jun; 18(2):241-5. PubMed ID: 10464714
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
Visser W; Beckmann I; Knook MA; Wallenburg HC
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
[TBL] [Abstract][Full Text] [Related]
11. Fluctuation of endogenous TNF alpha concentration in plasma in advanced cancer patients.
Muc-Wierzgoń M; Madej K; Baranowski M; Kokot T
J Biol Regul Homeost Agents; 1996; 10(1):25-6. PubMed ID: 9049778
[TBL] [Abstract][Full Text] [Related]
12. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
13. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
[TBL] [Abstract][Full Text] [Related]
14. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
Iglesias J; Marik PE; Levine JS;
Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
[TBL] [Abstract][Full Text] [Related]
18. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
Zhang D; Li J; Jiang Z; Yu B; Tang X
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
[TBL] [Abstract][Full Text] [Related]
19. [Role of the TNF system in the pathomechanism of bronchial asthma].
Halász A; Cserháti E; Cseh K
Orv Hetil; 2002 Mar; 143(11):553-7. PubMed ID: 12583324
[TBL] [Abstract][Full Text] [Related]
20. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
